ONCY

#3427
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
1.04
1.04
Jahresspanne
0.33
1.51
Tagesänderung
+10.64%
Monatliche Änderung
+14.29%
6 month change
+4.00%
Jahresänderung
+173.68%
Vorheriger Schlusskurs
0.9 4
Open
1.0 4
Tief
1.0 4
High
1.0 4
Volumen
30
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q4, 25Q1, 26 TTM

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Nachrichten